Cytosorbents targets operating cash flow breakeven in 2H 2026 while planning DrugSorb-ATR de novo submission in late 2026/early 2027

Blue Owl in talks to buy stake in NBA's Cleveland Cavaliers - report

2026/06/25

Envoy Medical ends its at-the-market equity facility

2026/06/25

TD SYNNEX declares $0.48 dividend

2026/06/25

Darden Restaurants raises dividend by 8% to $1.62

2026/06/25